Status:
COMPLETED
Viagra in the Treatment of Primary Dysmenorrhea
Lead Sponsor:
Milton S. Hershey Medical Center
Collaborating Sponsors:
National Institutes of Health (NIH)
Conditions:
Dysmenorrhea
Eligibility:
FEMALE
18-35 years
Phase:
PHASE1
PHASE2
Brief Summary
The primary hypothesis is that a 100mg single dose of sildenafil citrate (Viagra) will have a higher improvement rate when compared to placebo in the treatment of moderate to severe primary dysmenorrh...
Detailed Description
It is well established that excess prostaglandin production in primary dysmenorrhea leads to ischemia of the uterine muscle, which consequently causes pelvic pain. A large number of drugs have been st...
Eligibility Criteria
Inclusion
- Primary dysmenorrhea at current visit, with a visual analogue scale (VAS) score of \>35; pain defined as moderate or severe on a categorical of none, mild, moderate, severe.
Exclusion
- Secondary dysmenorrhea
- Any current medication
- Serious medical condition
Key Trial Info
Start Date :
May 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2011
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT00123162
Start Date
May 1 2007
End Date
August 1 2011
Last Update
December 23 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nova Gradiska General Hospital
Strossmayerova 17, Zagreb, Croatia